期刊文献+

我院2005~2007年常见细菌分离及药敏分析 被引量:4

下载PDF
导出
摘要 随着抗菌药物的发展和临床广泛使用.且近年来由于抗菌药物的滥用而引发的多种细菌的耐药株迅速增加.人们不得不对抗菌药物的应用采取更为慎重的态度.掌握临床常见致病菌群的分布及耐药性.抗菌药物的选择及合理应用.保证抗菌药物的临床效能是密切相关的。对我院2005~2007年临床标本细菌培养及耐药性结果进行统计分析供参考。
作者 蒋彬
出处 《实验与检验医学》 CAS 2008年第4期458-459,共2页 Experimental and Laboratory Medicine
  • 相关文献

参考文献3

二级参考文献18

  • 1刘晓莉,杨旭,单斌,杜廷义,黄云昆,吴肪.2002年昆明地区临床分离菌的耐药性监测及分析[J].中国抗感染化疗杂志,2004,4(4):202-205. 被引量:20
  • 2申正义,孙自镛,王洪波.湖北地区临床分离菌耐药性监测[J].中国抗感染化疗杂志,2004,4(5):263-267. 被引量:36
  • 3朱德妹,汪复,张婴元.2004年上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2005,5(4):195-200. 被引量:227
  • 4李景云,马越,张力,胡昌勤,金少鸿.临床52家医院常见分离菌株的药物敏感性监测[J].中华检验医学杂志,2006,29(5):452-457. 被引量:92
  • 5Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 6Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 7Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 8Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.
  • 9National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S12. National Committee for Clinical Laboratory Standards,Wayne, Pa.2002,1.
  • 10Chanawong A. M' Zali FH, Heritage J, et al. Three cefotaximases,CTX-M-9, CTX-M-13, CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002, 46:630-637.

共引文献782

同被引文献15

  • 1汪复.抗菌药物合理应用的几个问题[J].中国抗感染化疗杂志,2005,5(1):1-3. 被引量:99
  • 2杨晓军,吴万征,吴雪梅,戴湘春,谭玲.2002年~2004年我院抗菌药物的使用与细菌耐药性分析[J].中国药房,2006,17(8):594-596. 被引量:28
  • 3芮勇宇,耿穗娜,王前,裘宇容.临床分离4 364株细菌的分布特征和耐药性变迁分析[J].热带医学杂志,2007,7(3):250-253. 被引量:13
  • 4National Committee for Clinical Laboratory Standards.Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline.NCCLS document M100-17[S].Wayne (PA):NCCLS,2007.
  • 5American Hospital Association.AHA guide to the health care field 2007[S].Chicago:AHA Press,2006.
  • 6Rodriguez CA,Aqudelo M,Zuluaga AF,et al.In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxcillin[J].BMC Infectious Diseases,2010,153(10):1471-1484.
  • 7Kaase M,Baars B,Friedrich S,et al.Performance of MicroScan WalkAway and Vitek 2 for detection of oxacillin resistance in a set of methicillin-resistant Staphylococcus aureus isolates with diverse genetic backgrounds[J].J Clinical microbiol,2009,47(8):2623-2625.
  • 8Clinical and Laboratory Standards Institute. CLSI document M100- S20: Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement[S]. Wayne, PA, USA: Clinical and Laboratory Standards Institute, 2410.
  • 9王学军,黄晶,许建成,张传军.医院内细菌耐药监测及耐药谱研究[J].中国实验诊断学,2007,11(10):1398-1400. 被引量:2
  • 10张玉萍,裘霞雯.327株金黄色葡萄球菌耐药性分析[J].实验与检验医学,2008,26(1):87-87. 被引量:17

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部